Jens Schletter, PhD Novartis

Jens Schletter is currently working as Head Regulatory CMC Biosimilars Novartis. As such he is responsible for all regulatory CMC aspects of Novartis’ biosimilar approved drugs (filed by the Novartis company Sandoz) as well as biosimilar development projects, on a global level.

Overall Jens has more than 20 years of experience working in the biotech industry, including 18 years in the regulatory affairs function. Prior to joining Sandoz he held various regulatory affairs positions of increasing responsibilities in a number of German and US biotech companies .

Jens graduated in biopharmacology in Greifswald/Germany and did his PhD in biology at the University of Kiel/Germany. He also holds a Master degree in Drug Regulatory Affairs from the University of Bonn/Germany.